DYNC2H1-KIAA1377 Fusion FISH Probe
The DYNC2H1-KIAA1377 Fusion FISH Probe is used to confirm a fusion of the DYNC2H1 and KIAA1377 genes. The fusion of the DYNC2H1 and KIAA1377 genes has been associated with Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| DYNC2H1-KIAA1377-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-RERE | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-REOR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-REGO | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-REGR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-OROR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GORE | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GROR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| DYNC2H1-KIAA1377-20-AQAQ | 20 (40 μL) | 200 μL |
|
DYNC2H1 Gene Summary
This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
Gene Name: Dynein Cytoplasmic 2 Heavy Chain 1
Chromosome: CHR11: 102980159 -103350591
Locus: 11q22.3
Gene Diseases
The DYNC2H1 KIAA1377 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|